What does the evidence say about Boswellia Osteoarthritis Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Boswellia Osteoarthritis Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Nutritional supplements are increasingly used for KOA due to their low risk, but direct comparative evidence on their efficacy and safety remains scarce. [Zhang Y (2025); evidence level 1] - Background : Knee osteoarthritis (KOA) is a prevalent degenerative joint disease that can greatly affect quality of life in middle-aged and elderly individuals. [Zhang Y (2025); evidence level 1] - Between 1990 and 2020, OA prevalence increased by over 100%, and the years lived with disability (YLDs) have also risen sharply, creating a substantial economic burden on patients and healthcare systems []. [Patel Milan (2026); evidence level 3] - Risk factors such as age, obesity, prior joint injury, and genetics drive this alarming upward trend, especially obesity, as it accounts for a growing fraction of the OA burden worldwide. [Patel Milan (2026); evidence level 3] - Long-term use of NSAIDs or corticosteroids carries gastrointestinal and cardiovascular risk and often fails to protect cartilage []. [Patel Milan (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.